December 1, 2005
In the wake of Hurricane Katrina biotechnology researchers are moving forward with plans to build the New Orleans BioInnovation Center, an incubator for emerging biotechnology companies and future home of the Louisiana Gene Therapy Research Consortium clinical manufacturing facility.
Construction on the BioInnovation Center, which will be built at 1441 Canal Street, has been set back by about 60 days, but Tulane University, Louisiana State University and the state of Louisiana have renewed their commitment to complete the project by 2007. Tulane University Health Sciences Center and Louisiana State University Health Sciences Center are partners in the BioInnovation Center and other ongoing research and projects vital to restoring the New Orleans economy.
"Our most valuable asset is our intellectual capital, the clinicians, researchers and faculty of our institutions, and they are the key to successfully rebuilding our biomedical centers of excellence," said Paul Whelton, Louisiana Gene Therapy Research Consortium Board Chairman and Senior Vice President of Tulane's Health Sciences.
BioInnovation Centers in Shreveport and Baton Rouge have become economic engines for the community and critical assets for university biomedical research programs.
Both Whelton and Joseph Moerschbaecher, vice chancellor for academic affairs and dean of the School of Graduate Studies at Louisiana Health Sciences Center in New Orleans, stated that although buildings had been damaged many valuable research assets were protected and even in the aftermath of the storm, significant research grants have been received.
Tulane University, New Orleans, LA 70118 504-865-5000 email@example.com